Family · Pharmaceutical analytical standards
Rifampicin
A semi-synthetic antibiotic of the rifamycin family, obtained in Milan in 1965 and first marketed in Italy in 1968: it is a cornerstone of tuberculosis treatment and is also used against leprosy. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?The rifamycins are named after the French film Rififi (1955), a favourite of the researchers who discovered them in 1957 in a bacterium from a soil sample on the French Riviera.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
